Loading...
•
Dec 31, 2021
NeueHealth Q4 2021 Earnings Report
Reported fourth quarter and full year 2021 financial results.
Key Takeaways
Bright Health Group reported a Q4 2021 revenue of $962.3 million, a 167.5% increase year-over-year. However, the company experienced a GAAP Net Loss of $813.4 million and an Adjusted EBITDA loss of $790.1 million.
Achieved substantial growth in 2021, delivering $4 billion in Revenue.
Reached a significant scale milestone of serving over 1 million health plan lives for the start of 2022.
Experienced challenges during the year which resulted in worse than expected performance.
Focused on driving results off our scaled platform in 2022 and beyond.
NeueHealth
NeueHealth
Forward Guidance
For full year 2022, Bright Health Group expects a revenue of $6.8 to $7.1 billion and an adjusted EBITDA loss of $500 to $800 million.
Positive Outlook
- Bright Health Group’s total Revenue is expected to be $6.8 billion to $7.1 billion
- Enterprise Medical Cost Ratio between 90% and 94%.
- Bright HealthCare end-of-year membership is expected to be approximately 1,000,000
- NeueHealth Revenue is expected to be approximately $2.3 billion.
- Intercompany Revenue elimination is expected to be approximately $1.2 to $1.4 billion.
Challenges Ahead
- Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 and $800.0 million